Bramitob is a brand name for the antibiotic medication known as tobramycin, which is specifically formulated for inhalation use. It is primarily prescribed for individuals with cystic fibrosis, a genetic condition that leads to the production of thick, sticky mucus that can cause severe lung infections. Bramitob works by targeting and killing the bacteria Pseudomonas aeruginosa, a common cause of lung infections in cystic fibrosis patients. This antibiotic is designed for use with a nebulizer, a device that converts the liquid medication into a mist, allowing it to be inhaled directly into the lungs. By delivering the medication directly to the site of infection, Bramitob aims to improve lung function, reduce the frequency of lung infections, and enhance the overall quality of life for patients with cystic fibrosis.